| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | 3 | 2 | 22 | 18 | 14 | 2 | — | 3 | — | — | — | 1 |
| total | individual payouts | |
|---|---|---|
| 2026 | ‡‡‡ |
|
| 2025 | ‡‡‡ |
|
| 2024 | ‡‡‡ |
|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2018 | ‡‡‡ |
|
| 2024 | 2025 | 2026 | Q'26 | |
|---|---|---|---|---|
| Cash | 465.07 | 610.43 | 695.93 | 716.13 |
| Receivables | 67.01 | 74.01 | 95.67 | 102.96 |
| Inventory | 550.24 | 621.15 | 700.95 | 778.54 |
| Other | — | — | — | — |
| 1,282.50 | 1,492.80 | 1,686.10 | 1,824.40 |
| 2024 | 2025 | 2026 | Q'26 | |
|---|---|---|---|---|
| Payables | 253.34 | 295.77 | 327.90 | 372.64 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 994.21 | 1,075.68 | 1,118.09 | 1,154.12 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Apr | Jul | Oct | Jan | Year | |
|---|---|---|---|---|---|
| ’26 | 1,481.35 | 1,661.92 | — | — |
—
|
| ’26 | 1,329.50 | 1,504.76 | 1,529.35 | 1,801.77 |
6,165.38
|
| ’25 | 1,200.73 | 1,351.96 | 1,361.86 | 1,636.12 |
5,550.67
|
| ’24 | 1,113.67 | 1,272.20 | 1,281.17 | 1,486.19 |
5,153.24
|
| ’23 | 1,051.93 | 1,183.39 | 1,175.35 | 1,384.57 |
4,795.24
|
| ’22 | 927.42 | 1,157.73 | 1,131.42 | 1,332.20 |
4,548.76
|
| ’21 | 588.48 | 803.27 | 969.61 | 1,088.39 |
3,449.75
|
| Apr | Jul | Oct | Jan | Year | |
|---|---|---|---|---|---|
| ’26 | 15.48 | 376.26 | — | — |
—
|
| ’26 | 33.03 | 218.01 | 61.14 | 263.01 |
575.19
|
| ’25 | 58.55 | 105.26 | 18.55 | 320.47 |
502.83
|
| ’24 | 36.28 | 174.97 | 68.99 | 229.17 |
509.41
|
| ’23 | (79.56) | 47.89 | 25.49 | 148.90 |
142.73
|
| ’22 | 37.11 | 158.09 | 27.09 | 137.04 |
359.32
|
| ’21 | (59.65) | 174.87 | 99.45 | 71.15 |
285.81
|
| Apr | Jul | Oct | Jan | Year | |
|---|---|---|---|---|---|
| ’26 | (177.76) | 301.45 | — | — |
—
|
| ’26 | (13.13) | 156.62 | (22.76) | 194.28 |
315.02
|
| ’25 | 17.46 | 47.50 | (26.65) | 281.94 |
320.25
|
| ’24 | 3.37 | 129.36 | (3.53) | 180.58 |
309.79
|
| ’23 | (153.28) | 15.97 | (12.30) | 92.83 |
(56.78)
|
| ’22 | (5.48) | 95.05 | (26.30) | 33.62 |
96.89
|
| ’21 | (103.17) | 146.28 | 82.40 | 1.06 |
126.57
|
| Apr | Jul | Oct | Jan | Year | |
|---|---|---|---|---|---|
| ’26 | 1.30 | 2.78 | — | — |
—
|
| ’26 | 1.16 | 1.58 | 1.28 | 1.05 |
5.06
|
| ’25 | 0.65 | 1.24 | 1.10 | 1.28 |
4.26
|
| ’24 | 0.56 | 1.10 | 0.88 | 0.50 |
3.05
|
| ’23 | 0.33 | 0.64 | 0.40 | 0.34 |
1.70
|
| ’22 | 0.54 | 1.28 | 0.89 | 0.41 |
3.13
|
| ’21 | (1.41) | 0.35 | 0.78 | 0.29 |
0.01
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 17.81 | 23.55 | 33.86 | 41.89 | 59.97 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 30.82 | 38.13 | 56.37 | 83.94 | 85.43 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23,000 | 26,000 | 28,000 | 29,000 | 31,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.20 | 0.18 | 0.18 | 0.19 | 0.20 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,548.76 | 4,795.24 | 5,153.24 | 5,550.67 | 6,165.38 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 32.84% | 29.76% | 33.29% | 34.71% | 35.97% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 404.63 | 221.28 | 381.61 | 500.17 | 596.90 | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.90% | 4.61% | 7.41% | 9.01% | 9.68% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 310.62 | 159.70 | 287.67 | 402.46 | 464.92 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 105.67 | 102.34 | 102.49 | 115.43 | 128.53 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 46.41 | 51.45 | 55.59 | 59.89 | 68.36 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 3.17 | 1.71 | 3.10 | 4.34 | 5.15 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.67 | 1.53 | 5.50 | 5.43 | 6.38 | ‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.68) | (2.14) | (2.15) | (1.97) | (2.88) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.99 | (0.61) | 3.34 | 3.46 | 3.49 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.81 | 19.23 | 22.79 | 26.67 | 31.21 | ‡‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 98.02 | 93.20 | 92.70 | 92.68 | 90.19 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.09 | 16.02 | 12.30 | 12.77 | 14.10 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.62 | 0.53 | 0.68 | 0.93 | 1.06 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.61 | 1.42 | 1.67 | 2.08 | 2.33 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.78 | 0.69 | 0.80 | 1.01 | 1.12 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 36.70 | (57.91) | 13.36 | 17.51 | 22.01 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 359.32 | 142.73 | 509.41 | 502.83 | 575.19 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (262.43) | (199.51) | (199.62) | (182.58) | (260.17) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 96.89 | (56.78) | 309.79 | 320.25 | 315.02 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 304.27 | 347.35 | 288.30 | 417.12 | 568.01 | — | — | — |
Working Cap'
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,187.00 | 1,118.00 | — | — | — | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 741.01 | 735.36 | (465.06) | (610.43) | (695.93) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,745.74 | 1,792.68 | 2,112.54 | 2,471.50 | 2,815.29 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.47% | 4.27% | 7.38% | 9.33% | 9.76% | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.27% | 5.60% | 14.03% | 15.91% | 17.86% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.27% | 9.03% | 14.73% | 17.56% | 17.59% | ‡‡‡‡‡ | — | — |
ROE
|
Urban Outfitters, Inc. (URBN) has masterfully reinvented itself amid retail’s toughest challenges—from COVID lockdowns to inflation—driving revenue from $3.45 billion in 2016 to $5.15 billion in 2024, with analysts forecasting a blistering surge to $7.08 billion by 2028, implying 19% cumulative growth. Powerhouse brands like Anthropologie and Free People have fueled this momentum, outpacing a stagnant sector through digital sales (now over 30% of mix), international expansion, and the fast-scaling Nuuly subscription model. Operational efficiency shines with revenue per employee steady at $184K-$197K, even as headcount grew, positioning URBN for explosive multi-brand scaling.
Profitability is roaring back: gross margins hit 33.29% in 2024 (nearing pre-pandemic peaks), EPS rocketed 277% to $3.10 with projections to $6.38 by 2028, and ROE climbed to 14.73%. A fortress balance sheet boasts net cash, surging FCF per share ($3.34), and aggressive buybacks shrinking shares 14% since 2016—EV/FCF at a steal of 13.4x. Despite a recent 15-20% pullback from 2025 highs, valuations scream opportunity with PS at 0.68x and forward PE dropping to 11x.
Wall Street’s buzzing with ~23% average upside potential, betting on margin expansion to 35% and Nuuly hitting 10%+ of sales—though insider selling (over $133M, no buys) adds a cautionary note amid macro risks. URBN’s compounding growth story offers overweight appeal for bold portfolios; dive into the full analysis for the charts, projections, and buyback catalysts that could ignite the next leg higher.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.